One of the first companies in China to obtain production qualification for ND+AI+FADV+IBD vaccines,Inactivated
Newcastle Disease, Avian Influenza (H9 Subtype), Fowl Adenovirus and Infectious Bursal Disease Vaccine, Inactivated
- Indication / Application:Used for the prevention of Newcastle Disease(sub-genotype VII),Avian Influenza (H9N2 subtype clade 4.1.a and 4.1.b),Fowl Adenovirus（I GROUP Type C4、TypeE 8a/8b、Type D11) and Infectious Bursal Disease Virus.
- Manufacturing: Produced in GMP-certified facility
- Supply Mode: Bulk Supply / Distributor / OEM Available
- Origin: China
Generic Name
Newcastle Disease, Avian Influenza (H9 Subtype), Fowl Adenovirus and Infectious Bursal Disease Vaccine, Inactivated
Composition and Content
| Disease | Strain/Serotype | Antigen Content | Optional Strain(s) |
|---|---|---|---|
| ND | La Sota | ≥ 108.5 EID50/0.1ml | La Sota + A-VII |
| AI(H9N2) | Clade 9.4.2.5 | ≥ 108.5 EID50/0.1ml | H9 (9.4.1a); H9 (9.4.1b) |
| FAdV | FAdV-4 | ≥ 107.0 TCID50/dose | FAdV-2/FAdV-3/FAdV-5/FAdV-8a |
| FAdV-8b | ≥ 107.0 TCID50/dose | ||
| FAdV-11 | ≥ 107.0 TCID50/dose | ||
| IBD | B87 + rVP2 |
B87 ≥ 106.5 TCID50/dose |
CA; CF (W252); rVP2 (cIBDV; varIBDV; vvIBDV; nVarIBDV) |
| rVP2: AGP ≥ 1:8/dose |
Indications
For the prevention of Newcastle disease (La Sota strain), avian influenza (H9N2 subtype, clade 9.4.2.5), fowl adenovirus infection (serotypes 4, 8b, and 11), and infectious bursal disease. Immunity develops 14-21 days after vaccination and lasts for 3 months.
Dosage and Administration
Administer subcutaneously in the neck or intramuscularly:
Chickens 1-4 weeks of age: 0.3 mL per bird; chickens over 4 weeks of age: 0.5 mL per bird.
Adverse Reactions
Generally, no adverse reactions occur.
Specification
250 mL/bottle; 500 mL/bottle.
Storage and Shelf Life
Store at 2-8°C. Shelf life: 24 months.
Appearance
A uniform milky-white emulsion.
Precautions
- 1. Vaccinate healthy chickens only. Do not use in emaciated or sick chickens.
- 2. Before use, check for a damaged vial, missing label, foreign matter, or severe oil-water separation. Do not use if any abnormality is found.
- 3. Allow the vaccine to reach room temperature and shake thoroughly before use.
- 4. Use within 2 hours after first opening and prevent contamination.
- 5. This vaccine may be used with live Newcastle disease and infectious bronchitis vaccines to enhance cellular and mucosal immunity.
Features:
- 1.One injection provides four protections – an innovative breakthrough in China that improves disease prevention efficiency, enhances effectiveness, and reduces farm workload.
- 2.Serotype-matched, highly concentrated viral subunit antigens formulated in scientifically optimized proportions.
- 3.Adjuvant formulation ensures zero stress and delivers high-efficiency protection using compound vegetable oil technology.
- 4.The adoption of a customized H9 Avian Influenza strain model enables meeting the needs of different countries for prevalent strains.
- 5.The vaccine contains composite antigens from classical very virulent Infectious Bursal Disease virus (cvvIBDV) and novel variant IBDV (nvIBDV), offering improved cross-protection against both strains as an upgraded version of the company’s original inactivated IBD vaccine series.
Recommended Vaccination Schedule
| Vaccine Name | Immune Age | Immune Dose (ml) |
|---|---|---|
| ND + AI + FADV + IBD | 1 d or 7–10 d | 0.2 or 0.3 |